These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 15623618
21. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y. J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310 [Abstract] [Full Text] [Related]
23. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]. Wang Y, Liang Z, Yuan YH, Han Y, Liu YX, Liu N, Chen YT, Ritter G, Old LJ, Zhang LJ. Zhonghua Yi Xue Za Zhi; 2004 Mar 17; 84(6):464-8. PubMed ID: 15061963 [Abstract] [Full Text] [Related]
26. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA, Neel HB, Strome SE, Roche P. Head Neck; 2003 Jun 17; 25(6):457-63. PubMed ID: 12784237 [Abstract] [Full Text] [Related]
27. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development. Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ. Hum Reprod; 2007 Apr 17; 22(4):953-60. PubMed ID: 17208940 [Abstract] [Full Text] [Related]
28. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis. Hudolin T, Juretic A, Pasini J, Tomas D, Spagnoli GC, Heberer M, Dimanovski J, Kruslin B. Urology; 2006 Jul 17; 68(1):205-7. PubMed ID: 16806422 [Abstract] [Full Text] [Related]
29. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study. Bodey B, Bodey V, Siegel SE. In Vivo; 2008 Jul 17; 22(1):83-7. PubMed ID: 18396787 [Abstract] [Full Text] [Related]
34. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]. Zhang WM, Xiao G, Xie D, Zhang M, Guo AL, Wen JM. Ai Zheng; 2005 May 17; 24(5):622-6. PubMed ID: 15890110 [Abstract] [Full Text] [Related]
35. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA, Conway RM, Walsh-Conway N, Browning J, Freyer C, Cebon J, Madigan MC. Br J Ophthalmol; 2012 Mar 17; 96(3):451-8. PubMed ID: 22190731 [Abstract] [Full Text] [Related]
36. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. de Carvalho F, Vettore AL, Inaoka RJ, Karia B, Andrade VC, Gnjatic S, Jungbluth AA, Colleoni GW. Cancer Immun; 2011 Jan 20; 11():1. PubMed ID: 21247062 [Abstract] [Full Text] [Related]
37. NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU, Jones RL, Yee C. PLoS One; 2012 Jan 20; 7(2):e32165. PubMed ID: 22384167 [Abstract] [Full Text] [Related]
38. Immunomic analysis of human sarcoma. Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ. Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2651-6. PubMed ID: 12601173 [Abstract] [Full Text] [Related]
39. Melanoma or not? Cancer testis antigens may help. Lüftl M, Schuler G, Jungbluth AA. Br J Dermatol; 2004 Dec 04; 151(6):1213-8. PubMed ID: 15606517 [Abstract] [Full Text] [Related]
40. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Söling A, Schurr P, Berthold F. Anticancer Res; 1999 Dec 04; 19(3B):2205-9. PubMed ID: 10472332 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]